
Infections Affect Over Half of EU Long-Term Care Residents
In a 12-month longitudinal analysis of long-term care facility residents across European countries, 57% experienced at least one healthcare-associated infection (HAI), with respiratory tract and urinary tract infections being the most common and leading to significant hospitalisations and deaths.
METHODOLOGY:
Researchers conducted a longitudinal cohort study across nine European countries to examine the incidence of HAIs and their associated hospitalisations and mortality in residents of long-term care facilities.
They analysed 3029 residents (mean age, 80.9 years; 68% women) who stayed in their facilities, including general nursing homes, residential homes, and mixed facilities, throughout the 12-month study period.
Data were collected via standardised questionnaires covering facility characteristics, resident demographics, and details about HAIs; infections acquired within the facility or during temporary discharge were included.
The primary outcome was the incidence of HAIs; secondary outcomes included HAI-related hospitalisations (occurring between the onset and resolution) and HAI-associated deaths.
TAKEAWAY:
Overall, 57% of the residents experienced at least one HAI during follow-up, with an incidence rate of 1.8 (95% CI, 0.9-3.3) per 1000 resident days.
Respiratory tract infections were the most common HAIs (28.9%; 95% CI, 27.3-30.5), followed by urinary tract infections (18.7%; 95% CI, 17.2-20.3) and COVID-19 (17.6%; 95% CI, 16.5-18.8).
The incidence of HAI-related hospitalisations was 0.09 (95% CI, 0.05-0.21) per 1000 resident days; the highest incidence was observed for respiratory tract infections, followed by urinary tract infections and COVID-19.
Overall, 4.5% of HAIs were fatal, and respiratory tract infections were the most common cause, accounting for 2.3% of deaths.
IN PRACTICE:
"Nevertheless, these data shed important light on a highly relevant topic within a health-care setting that is often neglected," the authors of a commentary wrote.
"There is a need for ongoing surveillance of infections, work to validate surveillance definitions, and more epidemiological data (eg, pathogen-specific burden, contribution of outbreak vs sporadic infections, and added burden of antimicrobial resistance)," they added.
SOURCE:
This study was led by Enrico Ricchizzi, PhD, Settore Innovazione nei Servizi Sanitari e Sociali, Regione Emilia-Romagna, Bologna, Italy. It was published online on June 16, 2025, in The Lancet Infectious Diseases.
LIMITATIONS:
This study was limited by variability in implementation of the survey across participating facilities and the biased selection of long-term care facilities. The diverse types of facilities included introduced heterogeneity. Moreover, this study did not assess the effect of infection prevention measures or available local resources at each facility.
DISCLOSURES:
This study was supported by the European Centre for Disease Prevention and Control. The authors declared having no competing interests.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
3 hours ago
- Fox News
Why 'fibermaxxing' could help prevent disease, according to a top expert
Dr. Timothy Spector, a leading microbiome researcher and scientific co-founder of ZOE, shares why he's on board with "fibermaxxing,' the nutrition trend that helps to improve gut health and improve digestion.


New York Times
5 hours ago
- New York Times
China's Mosquito Crackdown Tests a City's Post-Covid Patience
In the southern Chinese city of Foshan, officials are engaged in an all-out battle against chikungunya, a painful, mosquito-borne viral disease that could spread across the country. Soldiers wearing masks are fogging parks and streets with insecticide. Drones have been deployed to identify mosquito breeding sites. Researchers have introduced giant 'elephant mosquitoes,' whose larvae prey on the virus-carrying mosquitoes, and thousands of mosquito-eating fish have been released into city ponds. A virus transmitted by the bites of infected mosquitoes, chikungunya is rarely fatal, but it does cause fever and severe joint pain. It has infected around 8,000 people in China in four weeks, mostly in Foshan, and is the country's largest outbreak of its kind since the virus first emerged in the country in 2008. Experts say rising global temperatures have led to warmer and wetter weather there, allowing mosquitoes to thrive. To fight the outbreak, the authorities are also drawing on a familiar playbook honed during the Covid pandemic — mobilizing the city of 10 million in a 'patriotic public health campaign.' For some, that is evoking unhappy memories. At building entrances in the city, workers spray residents with mosquito repellent before allowing them in. Community workers in red vests go door to door, inspecting homes and ordering residents to dump any stagnant water. Those who don't cooperate could be fined or, in serious cases, face criminal charges for 'obstructing the prevention of infectious diseases,' according to an illustrated government explainer. At least five households have had their electricity cut for not cooperating, according to a notice issued by a neighborhood committee in the district of Guicheng. Want all of The Times? Subscribe.


Bloomberg
6 hours ago
- Bloomberg
Macquarie to Buy Stake in Portuguese Hospital Group Luz Saude
Macquarie Group Ltd. is set to buy a minority stake in Portuguese hospital operator Luz Saude SA, outbidding rivals CVC Capital Partners Plc and KKR & Co., according to people familiar with the matter. Sydney-based Macquarie agreed to purchase about 40% of Luz Saude from Fidelidade-Companhia de Seguros SA, a Portuguese insurer controlled by Chinese conglomerate Fosun International Ltd, said the people, who asked not to be named because the information is confidential. The deal could be signed in the coming days and would give Luz Saude an enterprise value of more than €1 billion, one of the people said.